@article{bd8be9d3753646389fb22fa9050158ad,
title = "Apparent modulation of CD20 by rituximab: An alternative explanation [1] (multiple letters)",
keywords = "pharmacology: Antibodies, Anti-Idiotypic, immunology: Antibodies, Monoclonal, drug effects: Antigens, CD20, drug effects: Down-Regulation, Humans, drug therapy: Leukemia, B-Cell, Tumor Cells, Cultured",
author = "Cragg, {Mark S.} and Bayne, {Mike C.} and Illidge, {Timothy M.} and Thomas Valerius and Johnson, {Peter W N} and Glennie, {Martin J.} and Iman Jilani and Maher Albitar",
year = "2004",
month = may,
day = "15",
doi = "10.1182/blood-2003-12-4384",
language = "English",
volume = "103",
pages = "3989--3991",
journal = "Blood",
issn = "0006-4971",
publisher = "Elsevier BV",
number = "10",
}